Literature DB >> 22083485

Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.

Loren G Miller1, Jennifer Tan, Samantha J Eells, Esther Benitez, Allen B Radner.   

Abstract

Recurrent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections are an increasingly common problem. However, there are no data on the efficacy of decolonization regimens. We prospectively evaluated 31 patients with recurrent CA-MRSA skin infections who received nasal mupirocin, topical hexachlorophene body wash, and an oral anti-MRSA antibiotic. The mean number of MRSA infections after the intervention decreased significantly from baseline (0.03 versus 0.84 infections/month, P = <0.0001). This regimen appears promising at preventing recurrent CA-MRSA infections.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22083485      PMCID： PMC3264243          DOI： 10.1128/AAC.01608-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Treatment of community-associated methicillin-resistant Staphylococcus aureus infections.

Authors:  Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 2.  Staphylococcus aureus: a community pathogen.

Authors:  Loren G Miller; Sheldon L Kaplan
Journal:  Infect Dis Clin North Am       Date:  2009-03       Impact factor: 5.982

Review 3.  Prevention and control of methicillin-resistant Staphylococcus aureus.

Authors:  Todd D Gleeson
Journal:  Dis Mon       Date:  2008-12       Impact factor: 3.800

4.  Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.

Authors:  Loren G Miller; Franciose Perdreau-Remington; Arnold S Bayer; Binh Diep; Nelly Tan; Kiran Bharadwa; Jennifer Tsui; Joshua Perlroth; Anthony Shay; Grace Tagudar; Uzoma Ibebuogu; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2007-01-19       Impact factor: 9.079

5.  A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.

Authors:  Loren G Miller; Clifford Quan; Anthony Shay; Katayoun Mostafaie; Kiran Bharadwa; Nelly Tan; Kelli Matayoshi; Jason Cronin; Jennifer Tan; Grace Tagudar; Arnold S Bayer
Journal:  Clin Infect Dis       Date:  2007-01-12       Impact factor: 9.079

6.  Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy.

Authors:  Vanessa R Laibl; Jeanne S Sheffield; Scott Roberts; Donald D McIntire; Sylvia Trevino; George D Wendel
Journal:  Obstet Gynecol       Date:  2005-09       Impact factor: 7.661

7.  Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers.

Authors:  Kara B Mascitti; Jeffrey S Gerber; Theoklis E Zaoutis; Todd D Barton; Ebbing Lautenbach
Journal:  Am J Infect Control       Date:  2010-05       Impact factor: 2.918

8.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

9.  National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.

Authors:  Adam L Hersh; Henry F Chambers; Judith H Maselli; Ralph Gonzales
Journal:  Arch Intern Med       Date:  2008-07-28

10.  A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection.

Authors:  R Raz; D Miron; R Colodner; Z Staler; Z Samara; Y Keness
Journal:  Arch Intern Med       Date:  1996-05-27
View more
  15 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Recurrent furunculosis caused by a community-acquired Staphylococcus aureus strain belonging to the USA300 clone.

Authors:  Shirish Balachandra; Maria Pardos de la Gandara; Scott Salvato; Tracie Urban; Claude Parola; Chamanara Khalida; Rhonda G Kost; Teresa H Evering; Mina Pastagia; Brianna M D'Orazio; Alexander Tomasz; Herminia de Lencastre; Jonathan N Tobin
Journal:  Microb Drug Resist       Date:  2015-02-10       Impact factor: 3.431

3.  Community-associated methicillin-resistant Staphylococcus aureus transmission in households of infected cases: a pooled analysis of primary data from three studies across international settings.

Authors:  J Knox; M Van Rijen; A-C Uhlemann; M Miller; C Hafer; P Vavagiakis; Q Shi; P D R Johnson; G Coombs; M Kluytmans-Van Den Bergh; J Kluytmans; C M Bennett; F D Lowy
Journal:  Epidemiol Infect       Date:  2014-04-24       Impact factor: 2.451

4.  Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees.

Authors:  Michael W Ellis; Carey D Schlett; Eugene V Millar; Kenneth J Wilkins; Katrina B Crawford; Stephanie M Morrison-Rodriguez; Laura A Pacha; Rachel J Gorwitz; Jeffrey B Lanier; David R Tribble
Journal:  Clin Infect Dis       Date:  2014-03-14       Impact factor: 9.079

5.  Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure.

Authors:  Carey D Schlett; Eugene V Millar; Katrina B Crawford; Tianyuan Cui; Jeffrey B Lanier; David R Tribble; Michael W Ellis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

6.  Recurrent Methicillin-Resistant Staphylococcus aureus Cutaneous Abscesses and Selection of Reduced Chlorhexidine Susceptibility during Chlorhexidine Use.

Authors:  Ryan C Johnson; Carey D Schlett; Katrina Crawford; Jeffrey B Lanier; D Scott Merrell; Michael W Ellis
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

7.  Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Authors:  Loren G Miller; Robert S Daum; C Buddy Creech; David Young; Michele D Downing; Samantha J Eells; Stephanie Pettibone; Rebecca J Hoagland; Henry F Chambers
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

8.  Association of Environmental Contamination in the Home With the Risk for Recurrent Community-Associated, Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Justin Knox; Sean B Sullivan; Julia Urena; Maureen Miller; Peter Vavagiakis; Qiuhu Shi; Anne-Catrin Uhlemann; Franklin D Lowy
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

Review 9.  Staphylococcus aureus infections: transmission within households and the community.

Authors:  Justin Knox; Anne-Catrin Uhlemann; Franklin D Lowy
Journal:  Trends Microbiol       Date:  2015-04-09       Impact factor: 17.079

10.  Impact of Decolonization Protocols and Recurrence in Pediatric MRSA Skin and Soft-Tissue Infections.

Authors:  Steven T Papastefan; Christie Buonpane; Guillermo Ares; Beshoy Benyamen; Irene Helenowski; Catherine J Hunter
Journal:  J Surg Res       Date:  2019-05-06       Impact factor: 2.192
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.